Mylan receives DCGI approval in India for TB drug, Pretomanid
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
National Tuberculosis Elimination Program
MoHFW seeks export ban of anti-TB drugs
Delay in production and receipt of supply may cause acute shortage of these drugs, highlights Union Health Secretary